Twitter Linkedin-in

Gene Therapy Development & Manufacturing: In-Person

13 - 14 June 2022 | London, UK
+ Digital Day: 15 June 2022 | Online
Part of the
Cell Series
Cell Therapy
Analytics Symposium
Gene Therapy Development & Manufacturing: In-Person
3D Cell Culture:
In-Person
Cell UK:
In-Person
Book Now
Gene Therapy Development & Manufacturing
13 - 14 June 2022 | London, UK
+ Digital Day: 15 June 2022 | Online

Join over 250 scientific leaders engaging in scientific discussions on the latest strategies and technologies to accelerate gene therapy production.

Download Agenda
Register

Gene Therapy Development & Manufacturing: In-Person delivers in-depth discussion on optimised process strategies and technologies for the successful technical development and manufacture of advanced gene therapy products.

Programme

Benefits to attending include…

Connect with over 250 attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions. 

Gain insights into the innovative technologies in gene editing, including CRISPR, ZFNs and TALENS and the translation of these technologies to clinical research 

Featuring key case studies on advanced analytical strategies for gene therapy and vector development, to support the successful commercialisation of therapeutic products 

Supported digitally on our fully featured online event platform, with selected presentations available to watch on-demand and extensive networking features. 

This Year's Agenda at a Glance

Day One
  • Viral & non-viral vector safety & quality 
  • Delivery and dosage challenges for gene therapies 
  • Effective testing, characterisation & validation approaches 
  • Scalable and cost-effective production processes 
  • Balancing speed-to-market and product quality 
  • Internal vs external manufacturing 
  • CAR-T, TCR & Engineered NK cell therapies 
  • Applications of gene therapy in clinical research 
  • Challenges from clinic to commercialization 
Day Two
  • CRISPR, ZFNs, TALENS 
  • Translating gene editing to the clinic 
  • Standardisation & quality control for gene editing 
  • Bioassays & analytical chemistry 
  • Developing advanced analytical characterization methods 
  • Tools to predict patient response to gene therapy 

Key Speakers

The 2022 event again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.

Below were some of the key speakers from the Cell UK: In-Person 2021 event.

KEN MACNAMARA

Ken Macnamara

AskBio Europe

PERVINDER SAGOO

Pervinder Sagoo

Orchard Therapeutics

ANGELA JOHNSON

Angela Johnson

Sigilon Therapeutics

ARON STEIN

Aron Stein

Sangamo Therapeutics

KEI KISHIMOTO

Kei Kishimoto

Selecta Biosciences

VIBHA JAWA

Vibha Jawa

Bristol-Myers Squibb

Event Features​

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of on-site experiences.

Poster Display

Enhance your attendance with an A0 Poster, based in our main networking hall
Submit Abstract

Networking Drinks

Relax after a busy first day at the event with access to the vibrant drinks reception
Enquire

Supported Digitally

Can't attend in-person? Our fully featured online platform runs alongside the event.

Sponsorship

A range of customisable opportunities for lead generation, brand building and global business deals. Whether you’re looking to build business, product launch or increase visibility, we provide a variety of highly effective options to suit budget and requirement.
Download Brochure
"The number of available presentations allowed for a wider choice of sessions to attend, giving comfortable control over our own schedule. The variety of presenters, both academic and industrial as well as their varied backgrounds gave interesting variety in perspectives. The commercial stalls had ample space and didn’t feel crowded.”
Production ScientistBio-Rad Laboratories Ltd
“The stand was busy and we had several new leads. We spoke to people that are very difficult to get hold of normally.”
SalesChemometec
“The talks were very informative. From a vendors perspective, the booths were well positioned and there was plenty of breakout opportunities.”
EMEA Sales ManagerBrooks Life Sciences
"The speaker line-up and presentations were very good – there was good insights into status of gene and cell therapies. The opportunity for networking was great.”
Head of Launch PreparationBayer AG
“Interesting, new and reasonably well grouped with focussed sessions and high quality speakers. I also enjoyed the ‘group’ meal and co-location of the meeting.”
DirectorHead of Protein Sciences, UCB Pharma
“Good presentations, good program, well organized .”
Global Program Associate DirectorNovartis
Previous
Next
Content Hub Graphic
Oxford Global Content HUB
Access complementary resources including Webinars, Q&A Sessions, Newsletters and much more.
Carousel
Cell Series Post Event Report 2019
Event statistics, testimonials, feedback and 2020 early programme info
Webinar - David Schaffer, Uni Cali
Complimentary Webinar
Director of the Berkeley Stem Cell Center, David Schaffer: Engineering Defined, Scalable, 3D Biomaterial Culture Systems for Stem Cell Expansion & Differentation
Cell UK 2019 Newsletter Carousel
Cell Series Pre-Event Newsletter
Download industry insight from senior speakers and sponsors of this year's event
Webinar
Complimentary Webinar
Alison McVie-Wylie, Vice President of Clinical Development at Exonics Therapeutics: Preclinical Development For AAV Gene Therapy
Market Survey Carousel
Cell & Gene Therapy Market Survey 2019
Insights from industry experts on clinical development, manufacturing and commercialisation

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.